The view from Minneapolis

Robert Reich

Friends, 

I just received this from Phillip Cryan, a former student who lives in Minneapolis:

I got an unexpected, heartfelt “I love you” this afternoon from a Latino neighbor driving by in an SUV. He was stopped at a red light, and saw me trying to read his vehicle’s license plate. He knew that meant I was out patrolling for ICE, so he rolled down his tinted windows to shout out with a laugh “we’re not those assholes!” And then he thanked me for what I was doing and told me “I love you,” pumping his fist to his heart. - Link to article

 By Shirley N. Weber, PhD, California Secretary of State  

Californians can confidently claim this: California has made more significant reforms to our election laws and expanded voting rights than any other state.  

The relevance of this accomplishment deepens as we prepare to celebrate the 60^th anniversary of the Voting Rights Act next year. This landmark legislation began to undo our country’s long history of voter suppression, intimidation, and disenfranchisement that far too many Americans experienced at the polls for decades.  

Endo International plc

IF YOU, A CHILD IN YOUR CARE, OR ANOTHER LOVED ONE WERE HARMED BY ENDO OR A RELATED COMPANY, INCLUDING PAR OR AMS, OR THEIR PRODUCTS INCLUDING OPIOIDS, RANITIDINE, OR TRANSVAGINAL MESH, YOUR RIGHTS MAY BE AFFECTED BY DEADLINES IN THE ENDO BANKRUPTCY.

The deadline to file a claim in the bankruptcy is July 7, 2023, at 5:00 p.m. (prevailing Eastern Time). The deadline to object to Endo’s sale is July 7, 2023, at 4:00 p.m. (prevailing Eastern Time).

WHAT IS THIS ABOUT?

On August 16, 2022, Endo International plc and certain of its affiliates filed for chapter 11 bankruptcy in the United States Bankruptcy Court for the Southern District of New York. Certain Endo affiliates manufactured and/or sold, among other things, branded opioid medications (including but not limited to OPANA® (oxymorphone hydrochloride), OPANA® ER (oxymorphone hydrochloride extended release), and PERCOCET® (oxycodone and acetaminophen tablets)), generic opioid medications, generic ranitidine medications, and transvaginal mesh. This notice is intended to inform you of your rights in this bankruptcy regarding the bar date and proof of claim process and Endo’s proposed sale of substantially all of its assets.

WHAT IS A CLAIM?

A “claim” means a right to seek payment or other compensation. If you, a child in your care, or another loved one were harmed by Endo or a related company, including Par or American Medical Systems (AMS), or their products, including opioids, ranitidine, or transvaginal mesh, you may have a claim against one or more of these entities. To make a claim, you will need to submit a proof of claim in the bankruptcy case. You may file a claim on behalf of yourself, a child in your care (including a child exposed to opioids in the womb), or a deceased or disabled relative. Examples of claims that may be filed in the Endo bankruptcy include but are not limited to:

• Opioid Claims: Claims for death, addiction or dependence, lost wages, loss of consortium, or neonatal abstinence syndrome (sometimes referred to as “NAS”), among others. 
• Ranitidine claims: Claims for cancer, including bladder, esophageal, pancreatic, stomach, and liver cancer, among others.
• Transvaginal mesh claims: Claims for pelvic pain, infection, bleeding, among others.

WHAT DO YOU NEED TO KNOW ABOUT THE BAR DATE AND PROOF OF CLAIM PROCESS?